← Back to Vaccine Database

MV-014-212

Live attenuated vaccine · VDDBV0518

Target & Classification

SARS-CoV-2SARS-CoV-2
Live attenuated vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04798001 Phase 1COVID-19